| Product Code: ETC7909198 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Deep Vein Thrombosis Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Deep Vein Thrombosis Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Deep Vein Thrombosis Market - Industry Life Cycle |
3.4 Latvia Deep Vein Thrombosis Market - Porter's Five Forces |
3.5 Latvia Deep Vein Thrombosis Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Latvia Deep Vein Thrombosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about deep vein thrombosis (DVT) and its risk factors among the population in Latvia |
4.2.2 Growing adoption of advanced diagnostic techniques for early detection of DVT |
4.2.3 Rise in the geriatric population in Latvia, which is more prone to developing DVT |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities and expertise in the diagnosis and treatment of DVT in Latvia |
4.3.2 High cost associated with the treatment of DVT, leading to affordability issues for patients |
5 Latvia Deep Vein Thrombosis Market Trends |
6 Latvia Deep Vein Thrombosis Market, By Types |
6.1 Latvia Deep Vein Thrombosis Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Arixtra (Fondaparinux sodium), 2021- 2031F |
6.1.4 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Fragmin (Dalteparin sodium), 2021- 2031F |
6.1.5 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Eliquis (Apixaban), 2021- 2031F |
6.1.6 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Savaysa (Edoxaban), 2021- 2031F |
6.1.7 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Xarelto (Rivaroxaban), 2021- 2031F |
6.1.8 Latvia Deep Vein Thrombosis Market Revenues & Volume, By Abelacimab, 2021- 2031F |
7 Latvia Deep Vein Thrombosis Market Import-Export Trade Statistics |
7.1 Latvia Deep Vein Thrombosis Market Export to Major Countries |
7.2 Latvia Deep Vein Thrombosis Market Imports from Major Countries |
8 Latvia Deep Vein Thrombosis Market Key Performance Indicators |
8.1 Average time taken for diagnosis of DVT in Latvia |
8.2 Number of healthcare facilities offering specialized DVT treatment in Latvia |
8.3 Percentage of the population in Latvia undergoing regular DVT screenings based on age and risk factors |
9 Latvia Deep Vein Thrombosis Market - Opportunity Assessment |
9.1 Latvia Deep Vein Thrombosis Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Latvia Deep Vein Thrombosis Market - Competitive Landscape |
10.1 Latvia Deep Vein Thrombosis Market Revenue Share, By Companies, 2024 |
10.2 Latvia Deep Vein Thrombosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here